N04BC (Dopa and dopa derivatives)
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:ATCCode |
N04BC
|
| gptkbp:class |
WHO ATC Classification System
|
| gptkbp:drugClass |
Dopa and dopa derivatives
|
| https://www.w3.org/2000/01/rdf-schema#label |
N04BC (Dopa and dopa derivatives)
|
| gptkbp:includes |
gptkb:Levodopa
Levodopa and decarboxylase inhibitor Levodopa, decarboxylase inhibitor and COMT inhibitor |
| gptkbp:partOf |
gptkb:N04B_(Dopaminergic_agents)
|
| gptkbp:therapeuticArea |
Neurology
|
| gptkbp:usedFor |
gptkb:Parkinson's_disease
|
| gptkbp:bfsParent |
gptkb:N04B
|
| gptkbp:bfsLayer |
8
|